Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Prone Positioning on Mortality in Patients With Severe and Persistent Acute Respiratory Distress Syndrome (Proseva)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2011 by Hospices Civils de Lyon.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT00527813
First received: September 10, 2007
Last updated: November 8, 2011
Last verified: November 2011
  Purpose

We project to test the effect of prone position on mortality in severe ARDS patients (PaO2/FiO2<150 with FiO2 > or = 0.6 and positive end-expiratory pressure > or = 5 cmH2O). Ventilator will be set in accordance with current standards aiming at protecting the lungs from VALI. Patients will be randomized into two arms: prone group in which proning will be realized for at least 16 hours a day and supine group in which patients will stay in a semi-recumbent position. Primary end-point is 28-day mortality of all causes. Secondary end-points are 90-day mortality of all causes and incidence of ventilator-acquired pneumonia. Study sample was calculated to detect ability of proning to reduce mortality from 60 to 45% percent, at one-tailed alpha error of 5% and power of 90% and 230 patients are needed in each arm.


Condition Intervention
Acute Respiratory Distress Syndrome
Procedure: prone position

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: Effect of Prone Positioning on Mortality in Patients With Severe and Persistent Acute Respiratory Distress Syndrome

Resource links provided by NLM:


Further study details as provided by Hospices Civils de Lyon:

Primary Outcome Measures:
  • 28-day mortality from all causes [ Time Frame: 28 days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • 90-day mortality from all causes and incidence of ventilator-acquired pneumonia (VAP). [ Time Frame: 90 days ] [ Designated as safety issue: No ]

Estimated Enrollment: 460
Study Start Date: January 2008
Estimated Study Completion Date: November 2011
Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: A
prone position for at least 16 hours per day
Procedure: prone position
prone position for at least 16 hours per day
No Intervention: B
semi-recumbent position

Detailed Description:

The acute respiratory distress syndrome (ARDS) is an acute respiratory failure characterized by bilateral pulmonary infiltrates on frontal chest radiography, arterial oxygen tension (Pao2) to fraction of inspired oxygen (FiO2) ratio of 200 or less, and absence of evidence for left atrial hypertension. In-hospital mortality remains high: from 40 to 60%. Typical pathological findings include disruption of the alveolar epithelium, diffuse alveolar damage, hyaline membranes and pulmonary inflammation. Gas exchange is severely altered making of invasive mechanical ventilation required in most of the cases. Mechanical ventilation should be judiciously set in order to protect the lung from ventilator- associated lung injury (VALI). VALI is commonly seen as the expression of two main alveolar strains. The well documented one to date is over distension of alveoli when high tidal volumes are used. A North-American randomized controlled trial (RCT) has demonstrated that using low tidal volumes (6 ml per kilo of predicted weight) results in a 22% decrease in mortality when compared with high tidal volumes (12 ml per kilo of predicted weight). As suggested by an ancillary study of this trial, a reduced pulmonary inflammation is one of the contributing factors of this result. Therefore, minimizing VALI is a primary therapeutic goal. Low lung volume VALI is the second potential mechanism, though less well documented. It is expected to result from repetitive collapse and reopening of terminal respiratory units. Experimental data suggest that proning can reduce VALI by homogenizing lung strains. In ARDS patients, proning is mainly used due to its ability to improve gas exchange in 60 to 70% of patients. Nonetheless, 3 RCTs failed to demonstrate a significant effect on mortality of proning in three clinical situations: 1: acute lung injury, 2: hypoxemic acute respiratory failure, 3: ARDS. Post hoc analysis of one of them has suggested an effect of proning on mortality for the most hypoxemic sub-group. Studies limitations can explain lack of statistical significance as lack of power, heterogeneity of patients, insufficient duration of proning, high tidal volumes. Only one RCT was specifically designed for ARDS. Mortality was 25% lowest in the prone position arm, but this difference was not significant due to lack of power. So, the capability of proning to improve patient survival in ARDS is still an open question.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Adult patients aged 18 years or more, both gender
  2. Receiving endotracheal intubation and mechanical ventilation for less than 36 hours
  3. Presenting with a Severe ARDS :

    • Acute onset
    • PaO2/FiO2 ≤ 200 (≤ 26.7 kPa)
    • Bilateral pulmonary infiltrates on frontal chest radiography
    • Capillary wedge pressure < 18 mm Hg if measured or no evidence for left atrial hypertension
  4. During since 12-24 hours
  5. AND with severity criteria : PaO2/FiO2 < 150 mm Hg (< 20 kPa) under FiO2 ≥ 0.6, PEEP ≥ 5 cm H2O and a tidal volume equal to 6 ml/kg PBW.
  6. Written consent from patient's next of kin

Exclusion Criteria:

  1. contra-indication to the prone position

    • Intracranial pressure > 30 mm Hg or cerebral perfusion pressure < 60 mm Hg
    • Massive haemoptysis needing urgent surgical or radiological treatment
    • Tracheal or thoracic surgery in the last 15 days
    • Facial trauma or surgery in the last 15 days
    • Deep venous thrombosis or pulmonary embolism treated in the last 2 days
    • Cardiac pace maker implantation in the last 2 days
    • Unstable bone dislocations of rachis, femur, rib cage, pelvis
    • Mean systolic arterial pressure less than 70 mm Hg despite vasopressive therapy
    • Pregnancy
    • Bronchopleural fistula treated with a single anterior chest tube (risk of kinking in prone position)
  2. Exclusion criteria for respiratory raisons

    • Necessity to use NOi or almitrine
    • Extra body circulation for oxygenation and/or CO2 epuration
  3. Exclusion criteria linked to clinical context

    • Pulmonary transplantation
    • Burns ≥ 20% of body surface
    • Chronic respiratory insufficiency under home oxygen therapy or non invasive ventilation
    • Chronic disease supposed to be fatal in less than 1 year
    • Non invasive ventilation for more than 24 hours before enrollment
  4. Other exclusion criteria

    • Decision to stop life-supportive therapies before enrollment
    • Enrollment in an other trial testing an intervention and with mortality as primary end point in the last 30 days
    • Prior enrollment in the same study
    • Prone position before enrollment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00527813

Locations
France
Hôpital Croix Rousse
Lyon, France, 69317
Sponsors and Collaborators
Hospices Civils de Lyon
Investigators
Principal Investigator: Guerin Claude, MD Hospices Civils de Lyon
  More Information

No publications provided by Hospices Civils de Lyon

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Hospices Civils de Lyon
ClinicalTrials.gov Identifier: NCT00527813     History of Changes
Other Study ID Numbers: 2007.474
Study First Received: September 10, 2007
Last Updated: November 8, 2011
Health Authority: France:Comité de protection des personnes Sud Est IV

Keywords provided by Hospices Civils de Lyon:
acute respiratory distress syndrome
prone position
Acute respiratory distress syndrome (ARDS)

Additional relevant MeSH terms:
Acute Lung Injury
Respiratory Distress Syndrome, Adult
Respiratory Distress Syndrome, Newborn
Syndrome
Disease
Infant, Newborn, Diseases
Infant, Premature, Diseases
Lung Diseases
Lung Injury
Pathologic Processes
Respiration Disorders
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on November 25, 2014